Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.

Pyrrole-imidazole polyamides are versatile DNA minor groove binders and attractive therapeutic options against oncological targets, especially upon functionalization with an alkylating agent such as seco-CBI. These molecules also provide an alternative for oncogenes deemed "undruggable" at...

Full description

Bibliographic Details
Main Authors: Jason Lin, Kiriko Hiraoka, Takayoshi Watanabe, Tony Kuo, Yoshinao Shinozaki, Atsushi Takatori, Nobuko Koshikawa, Anandhakumar Chandran, Joe Otsuki, Hiroshi Sugiyama, Paul Horton, Hiroki Nagase
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5087912?pdf=render
id doaj-6ddeaa21b84b42e0834e8733972bd6ff
record_format Article
spelling doaj-6ddeaa21b84b42e0834e8733972bd6ff2020-11-25T00:23:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011110e016558110.1371/journal.pone.0165581Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.Jason LinKiriko HiraokaTakayoshi WatanabeTony KuoYoshinao ShinozakiAtsushi TakatoriNobuko KoshikawaAnandhakumar ChandranJoe OtsukiHiroshi SugiyamaPaul HortonHiroki NagasePyrrole-imidazole polyamides are versatile DNA minor groove binders and attractive therapeutic options against oncological targets, especially upon functionalization with an alkylating agent such as seco-CBI. These molecules also provide an alternative for oncogenes deemed "undruggable" at the protein level, where the absence of solvent-accessible pockets or structural crevices prevent the formation of protein-inhibitor ligands; nevertheless, the genome-wide effect of pyrrole-imidazole polyamide binding remain largely unclear to-date. Here we propose a next-generation sequencing-based workflow combined with whole genome expression arrays to address such issue using a candidate anti-cancer alkylating agent, KR12, against codon 12 mutant KRAS. Biotinylating KR12 enables the means to identify its genome-wide effects in living cells and possible biological implications via a coupled workflow of enrichment-based sequencing and expression microarrays. The subsequent computational pathway and expression analyses allow the identification of its genomic binding sites, as well as a route to explore a polyamide's possible genome-wide effects. Among the 3,343 KR12 binding sites identified in the human LS180 colorectal cancer genome, the reduction of KR12-bound gene expressions was also observed. Additionally, the coupled microarray-sequencing analysis also revealed some insights about the effect of local chromatin structure on pyrrole-imidazole polyamide, which had not been fully understood to-date. A comparative analysis with KR12 in a different human colorectal cancer genome SW480 also showed agreeable agreements of KR12 binding affecting gene expressions. Combination of these analyses thus suggested the possibility of applying this approach to other pyrrole-imidazole polyamides to reveal further biological details about the effect of polyamide binding in a genome.http://europepmc.org/articles/PMC5087912?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Jason Lin
Kiriko Hiraoka
Takayoshi Watanabe
Tony Kuo
Yoshinao Shinozaki
Atsushi Takatori
Nobuko Koshikawa
Anandhakumar Chandran
Joe Otsuki
Hiroshi Sugiyama
Paul Horton
Hiroki Nagase
spellingShingle Jason Lin
Kiriko Hiraoka
Takayoshi Watanabe
Tony Kuo
Yoshinao Shinozaki
Atsushi Takatori
Nobuko Koshikawa
Anandhakumar Chandran
Joe Otsuki
Hiroshi Sugiyama
Paul Horton
Hiroki Nagase
Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
PLoS ONE
author_facet Jason Lin
Kiriko Hiraoka
Takayoshi Watanabe
Tony Kuo
Yoshinao Shinozaki
Atsushi Takatori
Nobuko Koshikawa
Anandhakumar Chandran
Joe Otsuki
Hiroshi Sugiyama
Paul Horton
Hiroki Nagase
author_sort Jason Lin
title Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
title_short Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
title_full Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
title_fullStr Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
title_full_unstemmed Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
title_sort identification of binding targets of a pyrrole-imidazole polyamide kr12 in the ls180 colorectal cancer genome.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Pyrrole-imidazole polyamides are versatile DNA minor groove binders and attractive therapeutic options against oncological targets, especially upon functionalization with an alkylating agent such as seco-CBI. These molecules also provide an alternative for oncogenes deemed "undruggable" at the protein level, where the absence of solvent-accessible pockets or structural crevices prevent the formation of protein-inhibitor ligands; nevertheless, the genome-wide effect of pyrrole-imidazole polyamide binding remain largely unclear to-date. Here we propose a next-generation sequencing-based workflow combined with whole genome expression arrays to address such issue using a candidate anti-cancer alkylating agent, KR12, against codon 12 mutant KRAS. Biotinylating KR12 enables the means to identify its genome-wide effects in living cells and possible biological implications via a coupled workflow of enrichment-based sequencing and expression microarrays. The subsequent computational pathway and expression analyses allow the identification of its genomic binding sites, as well as a route to explore a polyamide's possible genome-wide effects. Among the 3,343 KR12 binding sites identified in the human LS180 colorectal cancer genome, the reduction of KR12-bound gene expressions was also observed. Additionally, the coupled microarray-sequencing analysis also revealed some insights about the effect of local chromatin structure on pyrrole-imidazole polyamide, which had not been fully understood to-date. A comparative analysis with KR12 in a different human colorectal cancer genome SW480 also showed agreeable agreements of KR12 binding affecting gene expressions. Combination of these analyses thus suggested the possibility of applying this approach to other pyrrole-imidazole polyamides to reveal further biological details about the effect of polyamide binding in a genome.
url http://europepmc.org/articles/PMC5087912?pdf=render
work_keys_str_mv AT jasonlin identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT kirikohiraoka identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT takayoshiwatanabe identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT tonykuo identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT yoshinaoshinozaki identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT atsushitakatori identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT nobukokoshikawa identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT anandhakumarchandran identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT joeotsuki identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT hiroshisugiyama identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT paulhorton identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
AT hirokinagase identificationofbindingtargetsofapyrroleimidazolepolyamidekr12inthels180colorectalcancergenome
_version_ 1725355965462609920